TestBank for Roach’s Introductory
Clinical Pharmacology 11th edition
100 correct answered
1. A nursingL instructorL isL preparingL aL teachingL planL forL aL groupL ofL nursingL studentsL
aboutL pharmacology.L WhenL describingL thisL topic, L theL instructorL wouldL focusL theL
discussionL onL whichL ofL theL followingL asL anL essentialL aspect?
A) DrugL name
B) DrugL class
C) DrugL action
D) DrugL
sourceL Ans:L CL
Feedback:
PharmacologyL isL theL studyL ofL drugsL andL theirL actionL onL livingL organisms.L Thus,L
anL essentialL aspectL ofL pharmacologyLisL drugL action.L AnL understandingL ofL theL drugL
name,L drugL class,L andL drugL sourceL isL important,L butL theL mostL criticalL aspectL
relatedL toL pharmacologyL isL howL theL drugL actsL inL theL body.
2. AL nursingL studentL isL preparingL toL administerL aL prescribedL drugL toL aL patient.L TheL
studentL reviewsL informationL aboutL theL drugL andL itsL actions.L WhichL ofL theL followingL
wouldL beL theL bestL choiceL forL obtainingL thisL information?L SelectL allL thatL apply.
A) NursingL instructor
B) NurseL assignedL toL theL patient
C) ClinicalL drugL reference
D) PrescribingL healthL careL provider
E) ClinicalL
pharmacistL Ans:L C,L E
Feedback:
AlthoughL theL nursingL studentL canL askL theL nursingL instructor,L theL nurseL assignedL toL
theL patient,L andL theL prescribingL healthL careL providerL forL informationL aboutL theL
drug,L theL bestL choicesL forL drugL informationL wouldL includeL anL appropriateL drugL
referenceL andL theL clinicalL pharmacist.
3. WhenL describingL theL variousL typesL ofL medicationsL toL aL groupL ofL nursingL
students,L aL nursingL instructorL wouldL identifyL whichL ofL theL followingL asL aL
sourceL forL derivingL medications?L SelectL allL thatL apply.
A) Plants
B) SyntheticL sources
C) Mold
D) Minerals
E) AnimalsL
Ans:L A,L B,L C,L
D,L E
Feedback:
MedicationsL areL derivedL fromL naturalL sources,L forL example,L plants,L molds,L minerals,L
andL animals,L asL wellL asL createdL syntheticallyL inL aL laboratory.
Page 1
,TestBank for Roach’s Introductory
Clinical Pharmacology 11th edition
100 correct answered
4. WhichL ofL theL followingL namesL mayL beL assignedL toL aL drugL duringL theL
processL ofL development?L SelectL allL thatL apply.
A) ChemicalL name
B) OfficialL name
C) PharmacologicL name
D) TradeL name
E) NonproprietaryL
nameL Ans:L A,L B,L D,L E
Feedback:
ThroughoutL theL processL ofL development,L drugsL mayL haveL severalL namesL assignedL
toL themL includingL aL chemicalL name,L aL genericL (nonproprietary)L name,L anL officialL
name,L andL aL tradeL orL brandL name.
5. AL drugL mayL beL classifiedL byL whichL ofL theL following?L SelectL allL thatL apply.
A) TheL chemicalL typeL ofL theL drug'sL activeL ingredient
B) TheL wayL theL drugL isL usedL toL treatL aL specificL condition
C) TheL genericL nameL ofL theL drug
D) TheL tradeL nameL ofL theL drug
E) TheL nonproprietaryL nameL ofL theL
drugL Ans:L A,L B
Feedback:
AL drugL mayL beL classifiedL byL theL chemicalL typeL ofL theL activeL ingredientL orL byL theL
wayL itL isL usedL toL treatL aL particularL condition.L Generic,L trade,L andL nonproprietaryL
referL toL howL aL drugL isL named.
6. AL groupL ofL nursingL studentsL areL reviewingL informationL aboutL theL processL ofL
drugL developmentL inL theL UnitedL States.L TheL studentsL demonstrateL understandingL
ofL thisL processL whenL theyL identifyL thatL whichL ofL theL followingL categoriesL areL
assignedL byL theL FoodL andL DrugL AdministrationL toL newlyL approvedL drugs?L
SelectL allL thatL apply.
A) Metabolite
B) NoncontrolledL substance
C) Prescription
D) Nonprescription
E) ControlledL
substanceL Ans:L C,L D,L E
Feedback:
OnceL drugsL areL approvedL forL use,L theL FDAL assignsL theL drugL toL oneL ofL theL
followingL categories:L prescription,L nonprescription,L orL controlledL substance.L
MetaboliteL refersL toL theL inactiveL formL ofL theL drug.L NoncontrolledL substanceL isL aL
termL thatL isL notL used.
Page 2
,TestBank for Roach’s Introductory
Clinical Pharmacology 11th edition
100 correct answered
7. WhichL ofL theL followingL wouldL beL mostL importantL forL theL nurseL toL doL toL ensureL
theL safeL useL ofL prescriptionL drugsL inL theL institutionalL setting?L SelectL allL thatL
apply.
A) AdministeringLdrugs
B) MonitoringL clientsL forL drugL effects
C) PrescribingL drugs
D) EvaluatingL clientsL forL toxicL effects
E) EducatingLclients/caregiversLaboutL
drugsL Ans:L A,L B,L D,L E
Feedback:
InL theL institutionalL setting,L theL nurse'sL roleL toL ensureL safeL useL ofL prescriptionL
drugsL includesL administeringL drugs,L monitoringL drugL effects,L evaluatingL forL toxicL
effects,L andL educatingL clientsL andL caregiversL aboutL drugs.
8. TheL nurseL isL helpingL aL clientL reviewL aL prescriptionL fromL theL healthL careL provider.L
WhenL examiningL theL prescription,L whichL ofL theL followingL wouldL theL nurseL
expectL toL findL documented?L SelectL allL thatL apply.
A) NameL ofL theL drug
B) DosageL ofL theL drug
C) RouteL ofL drugL administration
D) TimesL ofL drugL administration
E) LicensedLprescriber'sL
signatureL Ans:L A,L B,L C,L D,L E
Feedback:
TheL prescriptionL mustL containL theL client'sL name,L theL nameL ofL theL drug,L theL dosage,L
theL methodL andL timesL ofL administration,L andL theL signatureL ofL theL licensedL healthL
careL providerL prescribingL theL drug.
9. AfterL teachingL aL groupL ofL nursingL studentsL aboutL nonprescriptionL drugs,L theL
nursingL instructorL determinesL thatL theL teachingL wasL successfulL whenL theL studentsL
identifyL whichL ofL theL following?L SelectL allL thatL apply.
A) TheyL requireL aL licensedL healthL careL provider'sL signature.
B) TheyL areL referredL toL asL over-the-counterL drugs.
C) TheyL canL beL takenL withoutL riskL toL theL client.
D) TheyL haveL certainL labelingL requirements.
E) TheyLshouldL beL takenL onlyL asL directedL onL theL
label.L Ans:L B,L D,L E
Feedback:
NonprescriptionL drugsL areL oftenL referredL toL asL over-the-counterL (OTC)L drugs.L TheyL
doL notL requireL aL prescriptionL (aL licensedL healthL careL provider'sL signature)L butL doL
notL comeL withoutL riskL toL theL client.L TheL federalL governmentL hasL imposedL labelingL
requirementsL ofL OTCL drugsL andL theyL shouldL onlyL beL takenL asL directedL onL theL
labelL unlessL underL theL supervisionL ofL aL healthL careL provider.
Page 3
, TestBank for Roach’s Introductory
Clinical Pharmacology 11th edition
100 correct answered
10. AL nursingL studentL isL reviewingL informationL aboutL theL ControlledL SubstancesL
ActL ofL 1970.L TheL studentL wouldL expectL toL findL whichL ofL theL followingL asL beingL
regulatedL forL drugsL classifiedL asL controlledL substances?L SelectL allL thatL apply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensing
L Ans:L A,L C,L E
Feedback:
TheL ControlledL SubstancesL ActL ofL 1970L regulatesL theL manufacture,L distribution,L
andL dispensingL ofL drugsL classifiedL asL controlledL substances.L EliminationL refersL toL
theL excretionL ofL drugsL fromL theL body,L aL pharmacokineticL activity.L TheL actL doesL notL
addressL formulationL ofL theL drug.
11. WhenL reviewingL informationL aboutL theL OrphanL DrugL Program,L whichL ofL theL
followingL wouldL theL nurseL expectL toL find?L SelectL allL thatL apply.
A) TheL programL encouragesL theL developmentL andL marketingL ofL productsL toL treatL
rareL diseases.
B) TheL programL grantsL provisionalL approvalL withL aL writtenL commitmentL
fromL theL drugL companyL toL formallyL demonstrateL clientL benefits.
C) TheL programL providesL forL incentives,L suchL asL researchL grants,L protocolL
assistance,L andL specialL taxL credits,L toL developL productsL toL treatL rareL diseases.
D) TheL programL grantsL 7L yearsL ofL exclusiveL marketingL rightsL toL theL
manufacturerL ifL approved.
E) TheL programL acceleratesL approvalL ofL drugsL basedL onL preliminaryLevidenceL
beforeL formalL demonstrationL ofL clientL benefits.
Ans:L A,L C,L D
Feedback:
TheL OrphanL DrugL ProgramL encouragesL theL developmentL andL marketingL ofL productsL
usedL toL treatL rareL diseases.L TheL programL providesL incentivesL toL encourageL
manufacturersL toL developL orphanL drugs,L andL ifL approved,L theL manufacturerL hasL 7L
yearsL ofL exclusiveL marketingL rights.L AcceleratedL programsL involveL provisionalL
approvalL andL approvalL basedL onL preliminaryL evidence.
Page 4
Clinical Pharmacology 11th edition
100 correct answered
1. A nursingL instructorL isL preparingL aL teachingL planL forL aL groupL ofL nursingL studentsL
aboutL pharmacology.L WhenL describingL thisL topic, L theL instructorL wouldL focusL theL
discussionL onL whichL ofL theL followingL asL anL essentialL aspect?
A) DrugL name
B) DrugL class
C) DrugL action
D) DrugL
sourceL Ans:L CL
Feedback:
PharmacologyL isL theL studyL ofL drugsL andL theirL actionL onL livingL organisms.L Thus,L
anL essentialL aspectL ofL pharmacologyLisL drugL action.L AnL understandingL ofL theL drugL
name,L drugL class,L andL drugL sourceL isL important,L butL theL mostL criticalL aspectL
relatedL toL pharmacologyL isL howL theL drugL actsL inL theL body.
2. AL nursingL studentL isL preparingL toL administerL aL prescribedL drugL toL aL patient.L TheL
studentL reviewsL informationL aboutL theL drugL andL itsL actions.L WhichL ofL theL followingL
wouldL beL theL bestL choiceL forL obtainingL thisL information?L SelectL allL thatL apply.
A) NursingL instructor
B) NurseL assignedL toL theL patient
C) ClinicalL drugL reference
D) PrescribingL healthL careL provider
E) ClinicalL
pharmacistL Ans:L C,L E
Feedback:
AlthoughL theL nursingL studentL canL askL theL nursingL instructor,L theL nurseL assignedL toL
theL patient,L andL theL prescribingL healthL careL providerL forL informationL aboutL theL
drug,L theL bestL choicesL forL drugL informationL wouldL includeL anL appropriateL drugL
referenceL andL theL clinicalL pharmacist.
3. WhenL describingL theL variousL typesL ofL medicationsL toL aL groupL ofL nursingL
students,L aL nursingL instructorL wouldL identifyL whichL ofL theL followingL asL aL
sourceL forL derivingL medications?L SelectL allL thatL apply.
A) Plants
B) SyntheticL sources
C) Mold
D) Minerals
E) AnimalsL
Ans:L A,L B,L C,L
D,L E
Feedback:
MedicationsL areL derivedL fromL naturalL sources,L forL example,L plants,L molds,L minerals,L
andL animals,L asL wellL asL createdL syntheticallyL inL aL laboratory.
Page 1
,TestBank for Roach’s Introductory
Clinical Pharmacology 11th edition
100 correct answered
4. WhichL ofL theL followingL namesL mayL beL assignedL toL aL drugL duringL theL
processL ofL development?L SelectL allL thatL apply.
A) ChemicalL name
B) OfficialL name
C) PharmacologicL name
D) TradeL name
E) NonproprietaryL
nameL Ans:L A,L B,L D,L E
Feedback:
ThroughoutL theL processL ofL development,L drugsL mayL haveL severalL namesL assignedL
toL themL includingL aL chemicalL name,L aL genericL (nonproprietary)L name,L anL officialL
name,L andL aL tradeL orL brandL name.
5. AL drugL mayL beL classifiedL byL whichL ofL theL following?L SelectL allL thatL apply.
A) TheL chemicalL typeL ofL theL drug'sL activeL ingredient
B) TheL wayL theL drugL isL usedL toL treatL aL specificL condition
C) TheL genericL nameL ofL theL drug
D) TheL tradeL nameL ofL theL drug
E) TheL nonproprietaryL nameL ofL theL
drugL Ans:L A,L B
Feedback:
AL drugL mayL beL classifiedL byL theL chemicalL typeL ofL theL activeL ingredientL orL byL theL
wayL itL isL usedL toL treatL aL particularL condition.L Generic,L trade,L andL nonproprietaryL
referL toL howL aL drugL isL named.
6. AL groupL ofL nursingL studentsL areL reviewingL informationL aboutL theL processL ofL
drugL developmentL inL theL UnitedL States.L TheL studentsL demonstrateL understandingL
ofL thisL processL whenL theyL identifyL thatL whichL ofL theL followingL categoriesL areL
assignedL byL theL FoodL andL DrugL AdministrationL toL newlyL approvedL drugs?L
SelectL allL thatL apply.
A) Metabolite
B) NoncontrolledL substance
C) Prescription
D) Nonprescription
E) ControlledL
substanceL Ans:L C,L D,L E
Feedback:
OnceL drugsL areL approvedL forL use,L theL FDAL assignsL theL drugL toL oneL ofL theL
followingL categories:L prescription,L nonprescription,L orL controlledL substance.L
MetaboliteL refersL toL theL inactiveL formL ofL theL drug.L NoncontrolledL substanceL isL aL
termL thatL isL notL used.
Page 2
,TestBank for Roach’s Introductory
Clinical Pharmacology 11th edition
100 correct answered
7. WhichL ofL theL followingL wouldL beL mostL importantL forL theL nurseL toL doL toL ensureL
theL safeL useL ofL prescriptionL drugsL inL theL institutionalL setting?L SelectL allL thatL
apply.
A) AdministeringLdrugs
B) MonitoringL clientsL forL drugL effects
C) PrescribingL drugs
D) EvaluatingL clientsL forL toxicL effects
E) EducatingLclients/caregiversLaboutL
drugsL Ans:L A,L B,L D,L E
Feedback:
InL theL institutionalL setting,L theL nurse'sL roleL toL ensureL safeL useL ofL prescriptionL
drugsL includesL administeringL drugs,L monitoringL drugL effects,L evaluatingL forL toxicL
effects,L andL educatingL clientsL andL caregiversL aboutL drugs.
8. TheL nurseL isL helpingL aL clientL reviewL aL prescriptionL fromL theL healthL careL provider.L
WhenL examiningL theL prescription,L whichL ofL theL followingL wouldL theL nurseL
expectL toL findL documented?L SelectL allL thatL apply.
A) NameL ofL theL drug
B) DosageL ofL theL drug
C) RouteL ofL drugL administration
D) TimesL ofL drugL administration
E) LicensedLprescriber'sL
signatureL Ans:L A,L B,L C,L D,L E
Feedback:
TheL prescriptionL mustL containL theL client'sL name,L theL nameL ofL theL drug,L theL dosage,L
theL methodL andL timesL ofL administration,L andL theL signatureL ofL theL licensedL healthL
careL providerL prescribingL theL drug.
9. AfterL teachingL aL groupL ofL nursingL studentsL aboutL nonprescriptionL drugs,L theL
nursingL instructorL determinesL thatL theL teachingL wasL successfulL whenL theL studentsL
identifyL whichL ofL theL following?L SelectL allL thatL apply.
A) TheyL requireL aL licensedL healthL careL provider'sL signature.
B) TheyL areL referredL toL asL over-the-counterL drugs.
C) TheyL canL beL takenL withoutL riskL toL theL client.
D) TheyL haveL certainL labelingL requirements.
E) TheyLshouldL beL takenL onlyL asL directedL onL theL
label.L Ans:L B,L D,L E
Feedback:
NonprescriptionL drugsL areL oftenL referredL toL asL over-the-counterL (OTC)L drugs.L TheyL
doL notL requireL aL prescriptionL (aL licensedL healthL careL provider'sL signature)L butL doL
notL comeL withoutL riskL toL theL client.L TheL federalL governmentL hasL imposedL labelingL
requirementsL ofL OTCL drugsL andL theyL shouldL onlyL beL takenL asL directedL onL theL
labelL unlessL underL theL supervisionL ofL aL healthL careL provider.
Page 3
, TestBank for Roach’s Introductory
Clinical Pharmacology 11th edition
100 correct answered
10. AL nursingL studentL isL reviewingL informationL aboutL theL ControlledL SubstancesL
ActL ofL 1970.L TheL studentL wouldL expectL toL findL whichL ofL theL followingL asL beingL
regulatedL forL drugsL classifiedL asL controlledL substances?L SelectL allL thatL apply.
A) Manufacturing
B) Elimination
C) Distribution
D) Formulation
E) Dispensing
L Ans:L A,L C,L E
Feedback:
TheL ControlledL SubstancesL ActL ofL 1970L regulatesL theL manufacture,L distribution,L
andL dispensingL ofL drugsL classifiedL asL controlledL substances.L EliminationL refersL toL
theL excretionL ofL drugsL fromL theL body,L aL pharmacokineticL activity.L TheL actL doesL notL
addressL formulationL ofL theL drug.
11. WhenL reviewingL informationL aboutL theL OrphanL DrugL Program,L whichL ofL theL
followingL wouldL theL nurseL expectL toL find?L SelectL allL thatL apply.
A) TheL programL encouragesL theL developmentL andL marketingL ofL productsL toL treatL
rareL diseases.
B) TheL programL grantsL provisionalL approvalL withL aL writtenL commitmentL
fromL theL drugL companyL toL formallyL demonstrateL clientL benefits.
C) TheL programL providesL forL incentives,L suchL asL researchL grants,L protocolL
assistance,L andL specialL taxL credits,L toL developL productsL toL treatL rareL diseases.
D) TheL programL grantsL 7L yearsL ofL exclusiveL marketingL rightsL toL theL
manufacturerL ifL approved.
E) TheL programL acceleratesL approvalL ofL drugsL basedL onL preliminaryLevidenceL
beforeL formalL demonstrationL ofL clientL benefits.
Ans:L A,L C,L D
Feedback:
TheL OrphanL DrugL ProgramL encouragesL theL developmentL andL marketingL ofL productsL
usedL toL treatL rareL diseases.L TheL programL providesL incentivesL toL encourageL
manufacturersL toL developL orphanL drugs,L andL ifL approved,L theL manufacturerL hasL 7L
yearsL ofL exclusiveL marketingL rights.L AcceleratedL programsL involveL provisionalL
approvalL andL approvalL basedL onL preliminaryL evidence.
Page 4
